Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Interest Expenses (2016 - 2025)

Altimmune (ALT) has disclosed Interest Expenses for 16 consecutive years, with $876000.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 87500.0% to $876000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 18077.78% year-over-year, with the annual reading at $1.6 million for FY2025, 18077.78% up from the prior year.
  • Interest Expenses for Q4 2025 was $876000.0 at Altimmune, up from $495000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $876000.0 in Q4 2025, with the low at -$183000.0 in Q4 2022.
  • Average Interest Expenses over 5 years is $84650.0, with a median of $9000.0 recorded in 2021.
  • The sharpest move saw Interest Expenses crashed 3274.6% in 2021, then surged 87500.0% in 2025.
  • Over 5 years, Interest Expenses stood at -$62000.0 in 2021, then crashed by 195.16% to -$183000.0 in 2022, then soared by 101.09% to $2000.0 in 2023, then tumbled by 50.0% to $1000.0 in 2024, then soared by 87500.0% to $876000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $876000.0, $495000.0, and $264000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.